Evidence map›Paper›PMID 28219887›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Disruption of Pathogenic Cellular Networks by IL-21 Blockade Leads to Disease Amelioration in Murine Lupus.

Jin-Young Choi, Abhinav Seth, Michael Kashgarian, Sonia Terrillon, Emma Fung, Lili Huang, Li Chun Wang, Joe Craft

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 72 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. T cells in health and disease.Signal transduction and targeted therapy · 2023
    Review
  13. Article
  14. Article
  15. Article
  16. Glucose Requirement of Antigen-Specific Autoreactive B Cells and CD4+ T Cells.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  17. Article
  18. T cell help in the autoreactive germinal center.Scandinavian journal of immunology · 2022
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jin-Young ChoiSection of Rheumatology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.ORCID 0000-0002-7867-2427
Abhinav SethSection of Rheumatology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520.
Michael KashgarianDepartment of Pathology, Yale School of Medicine, New Haven, CT 06520.ORCID 0000-0003-0362-7688
Sonia TerrillonAbbVie Bioresearch Center, Worcester, MA 01605; and.
Emma FungAbbVie Bioresearch Center, Worcester, MA 01605; and.
Lili HuangAbbVie Bioresearch Center, Worcester, MA 01605; and.
Li Chun WangAbbVie Bioresearch Center, Worcester, MA 01605; and.
Joe CraftSection of Rheumatology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT 06520; joseph.craft@yale.edu.
AbbVie (United States) · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
TRAINING PROGRAM IN INVESTIGATIVE RHEUMATOLOGYT32AR007107 · NIAMS · YALE UNIVERSITY · PI RICHARD J BUCALA · 1986 to 2026
$7.5M
IMMUNE RESPONSES IN LUPUSR37AR040072 · NIAMS · YALE UNIVERSITY · PI CRAFT, JOSEPH EDGAR · 2000 to 2025
$7.4M
Yale Rheumatic Diseases Research Core CenterP30AR053495 · NIAMS · YALE UNIVERSITY · PI SHLOMCHIK, WARREN D · 2007 to 2017
$7.0M
Cis Regulatory Elements and Systemic Lupus ErythematosusR01AR068994 · NIAMS · YALE UNIVERSITY · PI CRAFT, JOSEPH EDGAR, GALLAGHER, PATRICK G · 2016 to 2020
$2.7M
NCATS NIH HHS UL1 TR001863NIAMS NIH HHS P30 AR053495NIAMS NIH HHS R01 AR068994NIAMS NIH HHS R37 AR040072NIAMS NIH HHS T32 AR007107
6 · The paper itself

Abstract

Systemic lupus erythematosus (lupus) is characterized by autoantibody-mediated organ injury. Follicular Th (Tfh) cells orchestrate physiological germinal center (GC) B cell responses, whereas in lupus they promote aberrant GC responses with autoreactive memory B cell development and plasma cell-derived autoantibody production. IL-21, a Tfh cell-derived cytokine, provides instructional cues for GC B cell maturation, with disruption of IL-21 signaling representing a potential therapeutic strategy for autoantibody-driven diseases such as systemic lupus erythematosus. We used blockade of IL-21 to dissect the mechanisms by which this cytokine promotes autoimmunity in murine lupus. Treatment of lupus-prone B6.

Indexed as

AnimalsAutoimmunityB-LymphocytesDisease Models, AnimalEnzyme-Linked Immunosorbent AssayEnzyme-Linked Immunospot AssayFlow CytometryInterleukin-21InterleukinsLupus Erythematosus, SystemicMaleMiceMice, Mutant StrainsReceptor Cross-TalkT-Lymphocytes, Helper-InducerInterleukin-21Interleukins

Identifiers

PMID28219887
PMCPMC5360548
OpenAlexW2589429492

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.